Advertisement

Therapeutic Implications of Understanding Pathogenesis: Clinical Relevance of Prognostic Factors

  • G. J. Mufti
Conference paper

Abstract

The prognostic factors for myelodysplastic syndromes (MDS) can be classified into clinical, morphological, cytogenetic, in vitro culture characteristics and the oncogene data which have recently become available.

Keywords

Myelodysplastic Syndrome Acute Leukaemia Karyotypic Abnormality Monocyte Count Normal Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Appelbaum FR, Storb R, Ramberg RE, Shulmann HM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Sanders J, Stewart P, Sullivan K, Witherspoon R, Thorns ED (1987) Treatment of preleukemic syndromes with marrow transplantation. Blood 69: 92–96PubMedGoogle Scholar
  2. 2.
    Armitage JO, Dick FR, Needleman SW, Burns CP (1981) Effect of chemotherapy for the dysmyelopoietic syndrome. Cancer Treat Rep 65: 601–605PubMedGoogle Scholar
  3. 3.
    Cazzola AM, Barosi G. Berzuini, Dacco M. Orlandi D, Stefanelli M, Ascari B (1982) Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol 50: 55–62PubMedCrossRefGoogle Scholar
  4. 4.
    Cheson BD, Jasperse DM, Simon R, Friedman MA (1986) A critical appraisal of low-dose cytosin arabinoside in patients with acute non-lymphatic leukaemina and myelodysplastic syndromes. J Clin Oncol 4: 1857–1864PubMedGoogle Scholar
  5. 5.
    Mufti GJ, Stevens JR, Oscier DG et al. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59: 425–433PubMedCrossRefGoogle Scholar
  6. 6.
    Pierre RV, Catovsky D, Mufti GJ et al. (1988) Clinical-cytogenetic correlations in myelodysplasia (preleukaemia). In: Report of the 6th International Workshop on Chromosomes in Leukaemia. London 1987. Cancer Genet Cytogenet 40: 149–161Google Scholar
  7. 7.
    Tricot GJK, Verwilghen RL (1986) Prognostic factors in the myelodysplastic syndromes. Scand J Haematol [Supp 45] 36: 107–113CrossRefGoogle Scholar
  8. 8.
    Varella BL, Chuang C, Woll JE et al. (1985) Modifications in the classification of primary myelodysplastic syndrome; the addition of a scoring system. Hematol Oncol 3: 55–63CrossRefGoogle Scholar
  9. 9.
    Worsley A, Oscier DG, Stevens J et al (1988) Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol 68: 17–21PubMedCrossRefGoogle Scholar
  10. 10.
    Yoshida Y, Oguma S, Uchino H, Maekawa T (1988) Haematological and prognostic variability of refractory anemias. Blut 56: C11 (Proceedings 1st international Symposium on MDS)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • G. J. Mufti

There are no affiliations available

Personalised recommendations